Abstract
Opioid and opioid-like receptors are activated by a variety of endogenous peptides including [Met]enkephalin (met), [Leu]enkephalin (leu), β-endorphin (β-end), α-neodynorphin, dynorphin A (dynA), dynorphin B (dynB), big dynorphin (Big dyn), nociceptin/orphanin FQ (N/OFQ); endomorphin-1 and endomorphin-2 are also potential endogenous peptides. The Greek letter nomenclature for the opioid receptors, μ, δ and κ, is well established, and NC-IUPHAR considers this nomenclature appropriate, along with the symbols spelled out (mu, delta, and kappa), and the acronyms, MOP, DOP, and KOP. [121, 100, 91]. The human N/OFQ receptor, NOP, is considered 'opioid-related' rather than opioid because, while it exhibits a high degree of structural homology with the conventional opioid receptors [294], it displays a distinct pharmacology. Currently there are numerous clinically used drugs, such as morphine and many other opioid analgesics, as well as antagonists such as naloxone, however only for the μ receptor.
Cite
CITATION STYLE
Borsodi, A., Bruchas, M., Caló, G., Chavkin, C., Christie, M. J., Civelli, O., … Zimmer, A. (2021). Opioid receptors in GtoPdb v.2021.3. IUPHAR/BPS Guide to Pharmacology CITE, 2021(3). https://doi.org/10.2218/gtopdb/f50/2021.3
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.